A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica

Calcified Tissue International

Volumn 58, Issue 2, 1996, Pages 73-80

  Healey, J H ^c   Paget, S A ^a,b   Williams Russo, P ^d   Szatrowski, T P ^a,b   Schneider, R ^a,b   Spiera, H ^d   Mitnick, H ^e   Ales, K ^a,b   Schwartzberg, P ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Department of Population Medicine and Diagnostic Sciences   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

Bone density; Calcitonin; Calcium and vitamin D supplement; Corticosteroid induced osteoporosis; Osteoporosis

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; CORTICOSTEROID; PLACEBO; SALCATONIN;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC POLYMYALGIA; SUBCUTANEOUS DRUG ADMINISTRATION; TEMPORAL ARTERITIS; VERTEBRA FRACTURE;

EID: 0030071479     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02529727     Document Type: Article

References (63)

1. Olbricht T, Benker G (1993) Glucocorticoid-induced osteoporosis: pathogenesis, prevention, and treatment, with special regard to the rheumatic diseases. J Int Med 234:237-244
2. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 112:352-364
3. Adachi JD, Bensen WG, Hodsman AB (1993) Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 22:375-384
4. Hosking DJ (1993) Effects of corticosteroid on bone turnover. Respir Med 87(suppl A):15-20
5. Healey JH (1994) Glucocorticoid-induced osteoporosis. Curr Opinions Orthop 5:33-38
6. Joffe I, Epstein S (1991) Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 20:256-272
7. Dykman TR, Gluck OS, Murphy WA, Han TJ, Han BH (1995) Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatoid arthritis. Arthritis Rheum 28:361-368
8. Reid IR, Heap SW (1990) Determinants of vertebral mineral density in patients receiving chronic glucocorticoid therapy. Arch Int Med 150:2545-2548
9. Reid IR, King AR, Alexander CJ, Ibbertson HK (1988) Prevention of steroid-induced osteoporosis with 3-amino-1-hydropropylidene 1, 1-bisphosphonate (ADP). Lancet 1:143-146
10. Montemurro L, Schiraldi G, Fraioli P (1991) Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49:71-76
11. Clements D, Compston JE, Evans WD, Rhodes J (1993) Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 34:1543-1546
12. Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265-268
13. LoCascio V, Adzmi S, Avioli LL, et al (1982) Suppressive effect of chronic glucocorticoid treatment of circulating calcitonin in man. Calcif Tissue Int 34:309-310
14. Reginster JY (1993) Calcitonin for prevention and treatment of osteoporosis. Am J Med 95:44S-47S
15. Gruber HE, Ivey JL, Baylink DJ (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295-303
16. Overgaard K, Hansen MA, Jensen SB, Cristiansen C (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. Br Med J 305:556-561
17. MacIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Healy MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet 1:900-902
18. Hunder GG, Bloch DA, Michel BA, et al (1990) The American College of Rheumatology Criteria for the Classification of Giant Cell Arteritis. Arthritis Rheum 33:1122-1128
19. Rodman GP, Schumacher R (1983) Polymyalgia rheumatica and temporal arteritis. In: Primer on the rheumatic disease, 8th ed. Arthritis Foundation. Atlanta, GA, pp 76-77
20. Chuang TY, Hunder GG, Ilstrup DM, Kurland GT (1982) Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 97:672-680
21. Williams-Russo PG, Healey JH, Szatrowski TP, Schneider R, Paget S, Ales K, Schwartzberg P (1995) Clinical reproducibility of dual energy X-ray absorptiometry. J Orthop Res 13:250-257
22. SAS Institute Inc (1985) SAS user's guide: statistics, version 5 edition. SAS Institute Inc. Cary, NC
23. Riggs B, Hodgson S, O'Fallon W, Chao E (1990) Effect of fluoride treatment on the fracture rate in post-menopausal women with osteoporosis. N Engl J Med 322:802-809
24. Williams-Russo P, Healey JH, Schneider R, Paget SA, Schwartzberg PR (1992) Interobserver consistency in the assessment of vertebral fracture on spine radiographs. Clin Res 40:139A
25. Kramer MS, Feinstein AR (1981) The biostatistics of concordance. Clin Pharmacol Ther 11-123
26. Cook DJ, Guyatt GH, Adachi JD, et al (1993) Quality of life issues in women with vertebral fracture due to osteoporosis. Arthritis Rheum 36:750-756
27. Kroger H, Honkanen R, Saarikoskis, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population-based study. Ann Rheum Dis 53:18-23
28. Jones SM, Bhalla AK (1993) Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 11:557-562
29. Guesens P, Dequeker J (1991) Locomotor side effects of corticosteroid. Baillieres Clin Rheumatol 5:99-118
30. Ansell BM (1991) Overview of the side effects of corticosteroid therapy. Clin Exp Rheumatol 9(suppl 6):19-20
31. Reid IR, Evans MC, Watti DH, Amers R, Cundy TF (1992) Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated patients. Osteoporosis Int 2:103-105
32. Jee WSS, Clark I (1981) Glucocorticoid osteoporosis. In: De Luca HP, Frost HM, Jee WSS, Johnston CC, Parfitt AM (eds) Osteoporosis. Recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 331-342
33. Schatz M, Dudl J, Zeiger RS, et al (1993) Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates. Allergy Proc 14:341-345
34. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726-1734
35. Hollister JR (1992) The untoward effects of steroid treatment on the musculoskeletal system and what to do about them [see comments]. J Asthma 29:363-368
36. Connolly CK, Francis RM, Murthy NK, Prescott RJ, Alcock SM (1992) Steroid-induced bone disease. Conflicting views of respiratory and bone physicians. J R Coll Physicians Lond 26:278-280
37. Ratcliffe MA, Lanham SA, Reid DM, Dawson AA (1992) Bone mineral density (BMD) in patients with lymphoma: the effects of chemotherapy, intermittent corticosteroid and premature menopause. Hematol Oncol 10:181-187
38. Olgaard K, Storm T, van Wowern N, et al (1992) Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort. Calcif Tissue Int 50L:490-497
39. Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosis 5:99-103
40. Luengo M, Picado C, DelRio L, Guanabens N, Monsterrat JM, Seotain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma: a one-year follow-up study. Am Rev Respir Dis 142:104-107
41. Shane E, Del C, Rivas M, Silverberg SJ, Kim TS, Staron RB, Bilezikien JP (1993) Osteoporosis after cardiac transplantation. Am J Med 94:257-264
42. Loftus J, Allen R, Hep R (1991) Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relative bone-sparing effect of deflazacort. Pediatrics 88:428-436
43. Gray RES, Dogherty SM, Galloway J, Coulton L, de Broe M, Kanis JA (1991) A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum 34:287-295
44. Ringe JD, Welzel D (1987) Salmon calcitonin in the therapy of corticosteroid-induced osteoporosis. Eur J Clin Pharmacol 33:35-39
45. Rizzato G, Tosi G, Schiraldi G, Montemurro L, Zanni D, Sisti S (1988) Bone protection with salmon calcitonin (SCT) in the long-term steroid therapy of chronic sarcoidosis. Sarcoidosis 5:99-103
46. Luengo M, Picado C, DelRio L, Guanabens N, Montserrat JM, Seotain J (1990) Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma: a one-year follow-up study. Am Rev Respir Dis 142:104-107
47. Laan RFJM, Buijs WCAM, van Ering LJTO, et al (1993) Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52:5-9
48. Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221-1225
49. Cooper C, O'Neill T, Silman A (1993) The epidemiology of vertebral fractures. European Verteral Osteoporosis Study Group. Bone 14(suppl 1):S89-S97
50. KleereKoper M, Nelson DA, Peterson EL, Tilley BC (1992) Outcome variables in osteoporosis trials. Bone 13(suppl 1):S29-S34
51. Reid IR, Ibbertson HK (1986) Calcium supplementation in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 44:287-290
52. Gennari C (1993) Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol 32(suppl 2):11-14
53. Reid IR, Heap SW, King AR, Ibbertson HK (1988) Two-year follow-up of bisphosphonate (ADP) treatment in steroid-induced osteoporosis. Lancet 2:1144
54. Bijlsma JWJ, Raymakers JA, Mosch C (1988) Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 6:113-119
55. Cranney A, Adachi JD, Bensen WG, et al (1993) Intermittent cyclic etidronate (ICE) prevents corticosteroid-induced bone loss. Calcif Tissue Int 52(suppl 1):s3A
56. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752
57. Wimalawansa SJ (1993) Long- and short-term side effects and safety of calcitonin in man. Calcif Tissue Int 52:90-93
58. Sambrook P, Birmingham J, Kelly P, et al (1993) Prevention of corticosteroid bone loss. Osteoporosis Int 3(suppl 1):141-143
59. Riis B, Thomsen K, Christiansen C (1993) Does calcium sup-plementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med 316:173
60. Recker RR (1993) Prevention of osteoporosis: calcium nutrition. Osteoporosis Int 3(suppl 1):163-165
61. Meunier PJ (1993) Is steroid-induced osteoporosis preventable? N Engl J Med 328:1781-1782
62. Sambrook PN, Spector TD (1993) Steroid osteoporosis: a pragmatic approach is needed while prospective trials are awaited. Br Med J 307:519-520
63. NIH Consensus Development Panel on Optimal Calcium Intake (1994) Optimal calcium intake: NIH Consensus Conference. JAMA 272:1942-1948